Canada Life’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.79M | Sell |
114,063
-5,872
| -5% | -$175K | 0.01% | 861 |
|
|
2025
Q4 | $3.58M | Sell |
119,935
-12,349
| -9% | -$403K | 0.01% | 898 |
|
|
2025
Q3 | $4.87M | Buy |
132,284
+15,396
| +13% | +$507K | 0.01% | 829 |
|
|
2025
Q2 | $4.21M | Sell |
116,888
-423
| -0.4% | -$15.7K | 0.01% | 867 |
|
|
2025
Q1 | $4.63M | Sell |
117,311
-11,326
| -9% | -$381K | 0.01% | 822 |
|
|
2024
Q4 | $3.87M | Sell |
128,637
-3,731
| -3% | -$107K | 0.01% | 966 |
|
|
2024
Q3 | $3.1M | Buy |
132,368
+117,894
| +815% | +$2.57M | 0.01% | 1100 |
|
|
2024
Q2 | $258K | Buy |
14,474
+2,003
| +16% | +$32K | ﹤0.01% | 1790 |
|
|
2024
Q1 | $190K | Hold |
12,471
| – | – | ﹤0.01% | 1836 |
|
|
2023
Q4 | $212K | Hold |
12,471
| – | – | ﹤0.01% | 1837 |
|
|
2023
Q3 | $104K | Buy |
12,471
+6,900
| +124% | +$96.2K | ﹤0.01% | 1955 |
|
|
2023
Q2 | $139K | Sell |
5,571
-1,111
| -17% | -$28.7K | ﹤0.01% | 1878 |
|
|
2023
Q1 | $101K | Hold |
6,682
| – | – | ﹤0.01% | 1979 |
|
|
2022
Q4 | $79K | Hold |
6,682
| – | – | ﹤0.01% | 2020 |
|
|
2022
Q3 | $40K | Hold |
6,682
| – | – | ﹤0.01% | 2139 |
|
|
2022
Q2 | $28K | Hold |
6,682
| – | – | ﹤0.01% | 2196 |
|
|
2022
Q1 | $68K | Hold |
6,682
| – | – | ﹤0.01% | 2093 |
|
|
2021
Q4 | $127K | Hold |
6,682
| – | – | ﹤0.01% | 1959 |
|
|
2021
Q3 | $224K | Hold |
6,682
| – | – | ﹤0.01% | 1886 |
|
|
2021
Q2 | $259K | Buy |
6,682
+44
| +0.7% | +$1.73K | ﹤0.01% | 1871 |
|
|
2021
Q1 | $317K | Sell |
6,638
-701
| -10% | -$33.7K | ﹤0.01% | 1840 |
|
|
2020
Q4 | $381K | Hold |
7,339
| – | – | ﹤0.01% | 1819 |
|
|
2020
Q3 | $196K | Buy |
7,339
+2,043
| +39% | +$47K | ﹤0.01% | 1907 |
|
|
2020
Q2 | $103K | Sell |
5,296
-94
| -2% | -$1.51K | ﹤0.01% | 2037 |
|
|
2020
Q1 | $53K | Hold |
5,390
| – | – | ﹤0.01% | 2117 |
|
|
2019
Q4 | $59K | Buy |
+5,390
| New | +$41K | ﹤0.01% | 2209 |
|
|
2019
Q3 | – | Sell |
-5,005
| Closed | -$43K | – | 2159 |
|
|
2019
Q2 | $43K | Sell |
5,005
-307
| -6% | -$2.32K | ﹤0.01% | 2480 |
|
|
2019
Q1 | $43K | Hold |
5,312
| – | – | ﹤0.01% | 2290 |
|
|
2018
Q4 | $21K | Hold |
5,312
| – | – | ﹤0.01% | 2535 |
|
|
2018
Q3 | $30K | Hold |
5,312
| – | – | ﹤0.01% | 2477 |
|
|
2018
Q2 | $70K | Buy |
+5,312
| New | +$73.1K | ﹤0.01% | 2317 |
|
|
2018
Q1 | – | Sell |
-10,839
| Closed | -$89K | – | 2723 |
|
|
2017
Q4 | $89K | Hold |
10,839
| – | – | ﹤0.01% | 2206 |
|
|
2017
Q3 | $127K | Hold |
10,839
| – | – | ﹤0.01% | 2083 |
|
|
2017
Q2 | $108K | Hold |
10,839
| – | – | ﹤0.01% | 2096 |
|
|
2017
Q1 | $126K | Hold |
10,839
| – | – | ﹤0.01% | 2040 |
|
|
2016
Q4 | $51K | Hold |
10,839
| – | – | ﹤0.01% | 2322 |
|
|
2016
Q3 | $84K | Hold |
10,839
| – | – | ﹤0.01% | 2201 |
|
|
2016
Q2 | $65K | Buy |
+10,839
| New | +$88.1K | ﹤0.01% | 2245 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
Canada Life's TGTX Position: Q1 2026 in Review
Canada Life reduced its TG Therapeutics (TGTX) stake by 4.9% in Q1 2026, selling an estimated $175K and leaving 114,063 shares worth $3.79M. The position accounts for 0.01% of the portfolio, ranked #861.
Canada Life first reported a position in TGTX in Q2 2016 and has held it in 38 quarters since. The position peaked at $4.87M in Q3 2025. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Canada Life held 114,063 shares of TG Therapeutics worth $3.79M as of Q1 2026.
- Canada Life sold 5,872 TG Therapeutics shares in Q1 2026, an estimated $175K.
- TG Therapeutics made up 0.01% of Canada Life's portfolio in Q1 2026, its #861 holding.
- Canada Life first reported a position in TG Therapeutics in Q2 2016 and has held it in 38 quarters since.
- Canada Life's TG Therapeutics position peaked at $4.87M in Q3 2025.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.